A plain-English guide to what peptides are, how they work, and why testing matters before you use them.
Peptides are short chains of amino acids — the same building blocks that make up proteins. The difference is size: amino acids are single units, proteins are long complex chains, and peptides sit in between, typically containing between 2 and 50 amino acids linked by peptide bonds.
Your body naturally produces thousands of distinct peptides, each with a specific job. Some act as hormones (insulin is a peptide). Others regulate inflammation, trigger cell repair, signal the release of growth hormone, or protect the gut lining. In this sense, peptides are not foreign to the body — they're part of its native signalling language.
Key distinction: Peptides are not the same as anabolic steroids. They work through the body's own signalling pathways rather than by directly mimicking sex hormones. That said, they are still potent biological molecules and carry real risks when misused or sourced from unverified suppliers.
The body's own peptides serve an enormous range of functions. Some well-understood examples include:
Synthetic peptides used in research are typically designed to mimic or enhance these natural signals — either by binding to the same receptors or by amplifying the body's own production of key compounds.
Research interest in peptides has grown significantly over the past decade, driven by a combination of genuine scientific findings, accessible synthesis technology, and online communities sharing self-experimentation data. The broad areas of interest include:
Peptides like BPC-157 and TB-500 have shown promising results in animal studies for accelerating tendon, ligament, and muscle repair. Athletes and people recovering from injury are drawn to these for their potential to reduce downtime, though human clinical data remains limited.
The commercial success of GLP-1 receptor agonists (semaglutide, tirzepatide) has driven enormous interest in the broader class of metabolic peptides. Retatrutide, a triple agonist targeting GLP-1, GIP, and glucagon receptors, has shown striking results in Phase 2 trials and is now widely sourced on the grey market despite not being approved.
Peptides such as Semax and Selank, originally developed in Russia, are researched for their effects on focus, memory, and anxiety. They work through neuroprotective and neurotrophic pathways rather than stimulant mechanisms.
GHK-Cu (copper peptide) has substantial research behind it for skin regeneration, collagen synthesis, and wound healing. It is one of the few peptides with meaningful human clinical data, appearing in both pharmaceutical and cosmetic research.
The vast majority of peptides used outside clinical settings are sourced from the grey market — typically Chinese or Indian synthesis facilities selling directly to consumers via websites labelled "for research use only." This creates a serious quality problem.
Unlike pharmaceuticals, grey market peptides have no regulatory oversight at any stage of production. Synthesis quality, sterility, packaging, storage, and labelling are entirely unverified. A 2024 peer-reviewed analysis found that products sold as "99% pure" by grey market vendors contained as little as 7.7% of the stated peptide, with more than 92% of the vial's contents being unidentified compounds.
Australian regulatory context: Most therapeutic peptides are classified as Schedule 4 (Prescription Only) under the Poisons Standard. Possession, supply, or importation without a valid prescription may constitute an offence under the Therapeutic Goods Act 1989 (Cth) and applicable state legislation. It is your responsibility to understand the legal status of any substance before obtaining it.
If you are researching a peptide, independent analytical testing is the only way to verify what you actually have. Vendor-issued certificates of analysis are typically generated by HPLC only — they confirm a peak is present but do not test for identity, sequence accuracy, endotoxin contamination, or true peptide content by mass.
Independent testing using LC-MS, RP-HPLC, MS/MS, and amino acid analysis provides a complete picture: what the compound is, whether the sequence is correct, how pure it is, and how much actual peptide is present relative to water and counter-ions (typically 60–80% in grey market samples).
Our NATA-accredited Australian lab partners provide comprehensive peptide analysis with results in 10 business days.
Order Testing → Understand the Risks